# ğŸ’¼ Revenue Model V1 (2025â€“2027)

**Owner:** Aubert

### ğŸ”¹ 1. Purpose

This document defines Memoraâ€™s revenue strategy across **B2C, B2B, and SDK channels**, including monetization assumptions, volume projections, risk dynamics, and breakeven path. It underpins investor decks, pilot partnership terms, and licensing decisions.

---

### ğŸ”¹ 2. Revenue Channels

| Stream | Description | Pricing | Volume Assumptions |
| --- | --- | --- | --- |
| **B2C Subscriptions** | Direct-to-caregiver plans for Companion access | $6.99/month CAD | 500 â†’ 25,000 users |
| **B2B Clinic Licensing** | Monthly license per clinic for multi-patient Companion + dashboard | $500/month/site | 5 â†’ 200 clinics |
| **SDK / Research Licensing** | White-label Companion exports or telemetry sharing for studies | Flat $10â€“25K/license | 1â€“2 per year |

---

### ğŸ”¹ 3. Revenue Timeline Snapshot

| Month | B2C Users | B2C Rev | Clinics | B2B Rev | SDK | Total Rev |
| --- | --- | --- | --- | --- | --- | --- |
| Apr-2025 | 500 | $3,495 | 5 | $2,500 | $10,000 | $15,995 |
| Jun-2025 | 2,000 | $13,980 | 12 | $6,000 | â€” | $19,980 |
| Sep-2025 | 5,000 | $34,950 | 30 | $15,000 | â€” | $49,950 |
| Jan-2026 | 10,000 | $69,900 | 60 | $30,000 | $20,000 | $119,900 |
| Jul-2026 | 18,000 | $125,820 | 120 | $60,000 | â€” | $185,820 |
| Mar-2027 | 25,000 | $174,750 | 200 | $100,000 | $25,000 | $299,750 |

> Cumulative revenue crosses $1.5M by Q1 2027 with an average blended monthly growth rate of ~11% from Q2 2025.

---

### ğŸ”¹ 4. Key Assumptions

| Area | Assumption |
| --- | --- |
| **B2C CAC** | $9.25 average per user (social, org partners, paid ads) |
| **B2B CAC** | $1,800 per clinic (via pilot conversion flow) |
| **Churn (B2C)** | ~4% monthly (improves with streak gamification) |
| **Gross Margin** | 84% blended margin (cloud cost, support, R&D amortized) |
| **SDK Risk** | Unpredictable cadence, but 80â€“90% margin on delivery |

---

### ğŸ”¹ 5. Strategic Insights & Levers

| Insight | Implication |
| --- | --- |
| **Clinic revenue is predictable** | Prioritize 6-month pilots with built-in conversion path |
| **B2C scales via networks** | Focus on Caregiver Org, Alzheimerâ€™s Society, and church group funnels |
| **SDK offsets dev cost** | Reinvest SDK revenue into Companion updates or IRB prep |
| **25K subs = breakeven ops** | Hit by Q1 2027 with minimal B2B dependency if CAC is controlled |

---

### ğŸ”¹ 6. Strategic Scenarios

| Scenario | Revenue Mix | Notes |
| --- | --- | --- |
| **Base Case** | 65% B2C, 30% B2B, 5% SDK | Current go-to-market plan |
| **Clinic-Heavy** | 45% B2C, 50% B2B, 5% SDK | Adds hospital networks and EMR integration |
| **B2C-Driven** | 80% B2C, 15% B2B, 5% SDK | Leverages community ambassadors, influencer channels |
| **SDK-Offset** | 60% B2C, 25% B2B, 15% SDK | Aligns with grant and R&D partnership cycles |

---

### ğŸ”¹ 7. Governance & Links

| Area | Linked Resource |
| --- | --- |
| CAC + LTV Models | ğŸ“ [CAC/LTV Forecast â€“ Clinics & B2C] |
| Forecasts | ğŸ“ˆ [18â€“24mo Model â€“ Memora] |
| Strategic Planning | ğŸ§­ [Memora GTM + Revenue Risks] |
| Compliance | ğŸ” [Grant-Linked Revenue Rules] |
| Subscription Scenarios | ğŸ’¬ [B2C Volume Forecasting Slides] |
